1. 'Cost-effectiveness of the three EMA-approved adjuvant systemic therapies in patients with high-risk melanoma: a model-based economic evaluation'. Issue 2 (February 2022) Authors: Mulder, Evalyn; Smit, Lisanne; Grünhagen, Dirk; Verhoef, Kees; Sleijfer, Stefan; van der Veldt, Astrid; Groot, Carin Uyl-de Journal: European journal of surgical oncology Issue: Volume 48:Issue 2(2022) Page Start: e50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 'Radiofrequency ablation for papillary microcarcinoma of the thyroid; a systematic review and meta-analysis.'. Issue 2 (February 2022) Authors: Van Dijk, Sam; Coerts, Hannelore; van Velsen, Evert F.S.; Peeters, Robin P.; Verhoef, Kees; van Ginhoven, Tessa M. Journal: European journal of surgical oncology Issue: Volume 48:Issue 2(2022) Page Start: e51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Association of CT-assessed sarcopenia with long-term oncological outcomes after curative therapy for colorectal liver metastasis. Issue 2 (February 2022) Authors: Meyer, Yannick; Galjart, Boris; Waalboer, Ruben; Grünhagen, Dirk; Verhoef, Kees Journal: European journal of surgical oncology Issue: Volume 48:Issue 2(2022) Page Start: e104 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Author's reply to: The real‐world outcome of metastatic melanoma: Unknown primary vs. known cutaneous. Issue 11 (3rd September 2019) Authors: Verver, Danielle; van der Veldt, Astrid A.M.; van Akkooi, Alexander C.J.; Verhoef, Kees; Grünhagen, Dirk J.; Louwman, Marieke W.J. Journal: International journal of cancer Issue: Volume 145:Issue 11(2019) Page Start: 3175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes. Issue 2 (13th August 2020) Authors: Klaver, Yarne; Rijnders, Maud; Oostvogels, Astrid; Wijers, Rebecca; Smid, Marcel; Grünhagen, Dirk; Verhoef, Kees; Sleijfer, Stefan; Lamers, Cor; Debets, Reno Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells. Issue 2 (7th September 2020) Authors: Campos Carrascosa, Lucia; van Beek, Adriaan A; de Ruiter, Valeska; Doukas, Michail; Wei, Jie; Fisher, Timothy S; Ching, Keith; Yang, Wenjing; van Loon, Karlijn; Boor, Patrick P C; Rakké, Yannick S; Noordam, Lisanne; Doornebosch, Pascal; Grünhagen, Dirk; Verhoef, Kees; Polak, Wojciech G; IJzermans... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells. Issue 2 (7th September 2020) Authors: Campos Carrascosa, Lucia; van Beek, Adriaan A; de Ruiter, Valeska; Doukas, Michail; Wei, Jie; Fisher, Timothy S; Ching, Keith; Yang, Wenjing; van Loon, Karlijn; Boor, Patrick P C; Rakké, Yannick S; Noordam, Lisanne; Doornebosch, Pascal; Grünhagen, Dirk; Verhoef, Kees; Polak, Wojciech G; IJzermans... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells. Issue 2 (7th September 2020) Authors: Campos Carrascosa, Lucia; van Beek, Adriaan A; de Ruiter, Valeska; Doukas, Michail; Wei, Jie; Fisher, Timothy S; Ching, Keith; Yang, Wenjing; van Loon, Karlijn; Boor, Patrick P C; Rakké, Yannick S; Noordam, Lisanne; Doornebosch, Pascal; Grünhagen, Dirk; Verhoef, Kees; Polak, Wojciech G; IJzermans... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells. Issue 2 (7th September 2020) Authors: Campos Carrascosa, Lucia; van Beek, Adriaan A; de Ruiter, Valeska; Doukas, Michail; Wei, Jie; Fisher, Timothy S; Ching, Keith; Yang, Wenjing; van Loon, Karlijn; Boor, Patrick P C; Rakké, Yannick S; Noordam, Lisanne; Doornebosch, Pascal; Grünhagen, Dirk; Verhoef, Kees; Polak, Wojciech G; IJzermans... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells. Issue 2 (7th September 2020) Authors: Campos Carrascosa, Lucia; van Beek, Adriaan A; de Ruiter, Valeska; Doukas, Michail; Wei, Jie; Fisher, Timothy S; Ching, Keith; Yang, Wenjing; van Loon, Karlijn; Boor, Patrick P C; Rakké, Yannick S; Noordam, Lisanne; Doornebosch, Pascal; Grünhagen, Dirk; Verhoef, Kees; Polak, Wojciech G; IJzermans... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗